Australia markets closed

PAVmed Inc. (PAVM)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.7200-0.0200 (-1.15%)
At close: 04:00PM EDT
1.7100 -0.01 (-0.58%)
After hours: 05:08PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 15.78M
Enterprise value 47.86M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.07
Price/book (mrq)7.42
Enterprise value/revenue 19.52
Enterprise value/EBITDA -0.63

Trading information

Stock price history

Beta (5Y monthly) 0.83
52-week change 3-74.74%
S&P500 52-week change 322.36%
52-week high 39.0000
52-week low 31.6000
50-day moving average 32.1783
200-day moving average 33.6235

Share statistics

Avg vol (3-month) 361.97k
Avg vol (10-day) 332.92k
Shares outstanding 59.17M
Implied shares outstanding 69.17M
Float 88.08M
% held by insiders 17.23%
% held by institutions 112.38%
Shares short (15 Apr 2024) 4406.87k
Short ratio (15 Apr 2024) 46.01
Short % of float (15 Apr 2024) 44.67%
Short % of shares outstanding (15 Apr 2024) 44.44%
Shares short (prior month 15 Mar 2024) 4368.67k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 307 Dec 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,561.77%

Management effectiveness

Return on assets (ttm)-98.73%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)2.45M
Revenue per share (ttm)0.34
Quarterly revenue growth (yoy)836.60%
Gross profit (ttm)N/A
EBITDA -65.86M
Net income avi to common (ttm)-66.27M
Diluted EPS (ttm)-9.1600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)22.31M
Total cash per share (mrq)2.43
Total debt (mrq)48.73M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.45
Book value per share (mrq)-6.62

Cash flow statement

Operating cash flow (ttm)-52.04M
Levered free cash flow (ttm)-27.92M